1Y Close · As of Aug 26, 2026
REMED operates in the Medical, Precision & Optical sector.
Legal name: REMED CO.,LTD.
In fiscal year 2025, REMED (302550) reported revenue of 24.5 billion KRW, down 4.1% from 25.6 billion KRW a year earlier.
Operating profit was 726 million KRW and net income was -35 million KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 83.9 billion KRW, with a P/B of 2.13.
These figures can be verified in the DART filing (receipt no. 20260626000758).
Recent Filings
Large Shareholding Report (General)
Large Shareholding Report (General)
Material Event Report (Treasury Trust Contract)
Checks
1 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: Treasury stock filings in the last 3 years: 1 cancellation(s).
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Market Action: No market actions recorded in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-26 | Large Shareholding Report (General) |
| 2026-08-20 | Large Shareholding Report (General) |
| 2026-08-03 | Material Event Report (Treasury Trust Contract) |
| 2026-08-03 | Trust Termination Report |
| 2026-08-03 | Material Event Report (Treasury Trust Termination) |